ML22034A628: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot change) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 19: | Line 19: | ||
=Text= | =Text= | ||
{{#Wiki_filter:Chapter 14 - Technical Specifications Table of Contents | {{#Wiki_filter:Chapter 14 - Technical Specifications Table of Contents CHAPTER 14 TECHNICAL SPECIFICATIONS TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 14-i Rev. 0 14.1 TECHNICAL SPECIFICATIONS......................................................................... 14.1-1 | ||
CHAPTER 14 | |||
TECHNICAL SPECIFICATIONS | |||
TABLE OF CONTENTS | |||
Section | |||
14.1 TECHNICAL SPECIFICATIONS......................................................................... 14.1-1 | |||
==14.2 REFERENCES== | ==14.2 REFERENCES== | ||
.................................................................................................... 14.2-1 | .................................................................................................... 14.2-1 | ||
SHINE Medical Technologies 14- | Chapter 14 - Technical Specifications List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 14-ii Rev. 0 None | ||
LIST OF | Chapter 14 - Technical Specifications List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 14-iii Rev. 0 None | ||
Chapter 14 - Technical Specifications Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 14-iv Rev. 0 ANS American Nuclear Society ANSI American National Standards Institute | |||
Chapter 14 - Technical Specifications Technical Specifications SHINE Medical Technologies 14.1-1 Rev. 0 CHAPTER 14 - TECHNICAL SPECIFICATIONS 14.1 TECHNICAL SPECIFICATIONS The SHINE technical specifications were developed following the format and content guidance of American National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and incorporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 1996b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2012a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical specifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines. | |||
SHINE Medical Technologies 14- | |||
CHAPTER 14 - TECHNICAL SPECIFICATIONS | |||
14.1 TECHNICAL SPECIFICATIONS | |||
The SHINE technical specifications were developed following the format and content guidance of American National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and incorporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 1996b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2012a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical specifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines. | |||
Observance of these technical specifications limits the likelihood and consequences of malfunctions. | Observance of these technical specifications limits the likelihood and consequences of malfunctions. | ||
SHINE Medical Technologies 14. | Chapter 14 - Technical Specifications References SHINE Medical Technologies 14.2-1 Rev. 0 | ||
==14.2 REFERENCES== | ==14.2 REFERENCES== | ||
ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007. | ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007. | ||
USNRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996. | USNRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996. | ||
USNRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, February 1996. | USNRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, February 1996. | ||
USNRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 27, 2012. | USNRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 27, 2012. | ||
USNRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, October 27, 2012.}} | |||
USNRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, October 27, 2012. | |||
Latest revision as of 18:41, 27 November 2024
| ML22034A628 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 01/26/2022 |
| From: | SHINE Technologies, SHINE Health. Illuminated |
| To: | Office of Nuclear Reactor Regulation |
| Shared Package | |
| ML22034A612 | List: |
| References | |
| 2022-SMT-0007 | |
| Download: ML22034A628 (6) | |
Text
Chapter 14 - Technical Specifications Table of Contents CHAPTER 14 TECHNICAL SPECIFICATIONS TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 14-i Rev. 0 14.1 TECHNICAL SPECIFICATIONS......................................................................... 14.1-1
14.2 REFERENCES
.................................................................................................... 14.2-1
Chapter 14 - Technical Specifications List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 14-ii Rev. 0 None
Chapter 14 - Technical Specifications List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 14-iii Rev. 0 None
Chapter 14 - Technical Specifications Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 14-iv Rev. 0 ANS American Nuclear Society ANSI American National Standards Institute
Chapter 14 - Technical Specifications Technical Specifications SHINE Medical Technologies 14.1-1 Rev. 0 CHAPTER 14 - TECHNICAL SPECIFICATIONS 14.1 TECHNICAL SPECIFICATIONS The SHINE technical specifications were developed following the format and content guidance of American National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and incorporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 1996b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2012a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical specifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines.
Observance of these technical specifications limits the likelihood and consequences of malfunctions.
Chapter 14 - Technical Specifications References SHINE Medical Technologies 14.2-1 Rev. 0
14.2 REFERENCES
ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.
USNRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.
USNRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, February 1996.
USNRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 27, 2012.
USNRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2, U.S. Nuclear Regulatory Commission, October 27, 2012.